PubMed

Effect of vitamin D on bone mineral density of elderly patients with osteoporosis responding poorly to bisphosphonates.

Heckman GA, Papaioannou A, Sebaldt RJ, Ioannidis G, Petrie A, Goldsmith C, Adachi JD.

BMC Musculoskelet Disord. 2002;3:6. Epub 2002 Feb 8.PMID: 11860614 [PubMed]Related articlesFree article

The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis.

Deane A, Constancio L, Fogelman I, Hampson G.

BMC Musculoskelet Disord. 2007 Jan 10;8:3.PMID: 17214897 [PubMed - indexed for MEDLINE]Related articlesFree article

Are oral bisphosphonates effective in improving lumbar bone mineral density in breast cancer survivors with osteopenia or osteoporosis?

Sawka AM, Ioannidis G, Papaioannou A, Thabane L, Olszynski WP, Brown JP, Hanley DA, Murray TM, Josse RG, Sebaldt RJ, Petrie A, Tenenhouse A, Goldsmith CH, Boulos P, Kouroukis T, Adachi JD.

J Obstet Gynaecol Can. 2005 Aug;27(8):759-64.PMID: 16287007 [PubMed - indexed for MEDLINE]Related articles

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.PMID: 18088161 [PubMed - indexed for MEDLINE]Related articles

Effect of alendronate treatment on bone mineral density in male patients with osteoporosis.

Drake AJ 3rd, Brietzke SA, Aprill BS, Shakir KM.

Endocr Pract. 1999 Jul-Aug;5(4):184-90.PMID: 15251673 [PubMed]Related articles

Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.

Kaskani E, Lyritis GP, Kosmidis C, Galanos A, Andypas G, Chorianopoulos K, Giagiosis A, Iliadou K, Karagianis A, Katsimichas K, Koskinas A, Matsouka K.

Clin Rheumatol. 2005 Jun;24(3):232-8. Epub 2005 Jan 13.PMID: 15647969 [PubMed - indexed for MEDLINE]Related articles

Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial.

Barone A, Giusti A, Pioli G, Girasole G, Razzano M, Pizzonia M, Palummeri E, Bianchi G.

J Am Geriatr Soc. 2007 May;55(5):752-7.PMID: 17493196 [PubMed - indexed for MEDLINE]Related articles

Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis.

Guaraldi G, Orlando G, Madeddu G, Vescini F, Ventura P, Campostrini S, Mura MS, Parise N, Caudarella R, Esposito R.

HIV Clin Trials. 2004 Sep-Oct;5(5):269-77.PMID: 15562367 [PubMed - indexed for MEDLINE]Related articlesFree article

Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.

Richy F, Schacht E, Bruyere O, Ethgen O, Gourlay M, Reginster JY.

Calcif Tissue Int. 2005 Mar;76(3):176-86. Epub 2005 Feb 7.PMID: 15692726 [PubMed - indexed for MEDLINE]Related articles

Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment.

Sebba AI.

Clin Ther. 2008 Mar;30(3):443-52. Review. Erratum in: Clin Ther. 2008 Jun;30(6):1177-8. PMID: 18405784 [PubMed - indexed for MEDLINE]Related articles

Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.

Meier C, Woitge HW, Witte K, Lemmer B, Seibel MJ.

J Bone Miner Res. 2004 Aug;19(8):1221-30. Epub 2004 May 24.PMID: 15231008 [PubMed - indexed for MEDLINE]Related articles

Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients.

Dobnig H, Hofbauer LC, Viereck V, Obermayer-Pietsch B, Fahrleitner-Pammer A.

Osteoporos Int. 2006;17(5):693-703. Epub 2006 Jan 25.PMID: 16435076 [PubMed - indexed for MEDLINE]Related articles

Changes in bone mineral density in premenopausal women with rheumatoid arthritis during a two-year follow-up.

Hämäläinen H, Kaarela K, Kröger H, Kauppi M, Järvenpää S, Hakala M, Kotaniemi A.

Joint Bone Spine. 2007 Oct;74(5):482-7. Epub 2007 May 30.PMID: 17905634 [PubMed - indexed for MEDLINE]Related articles

Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.

McComsey GA, Kendall MA, Tebas P, Swindells S, Hogg E, Alston-Smith B, Suckow C, Gopalakrishnan G, Benson C, Wohl DA.

AIDS. 2007 Nov 30;21(18):2473-82.PMID: 18025884 [PubMed - indexed for MEDLINE]Related articles

Osteoporosis in inflammatory bowel disease: effect of calcium and vitamin D with or without fluoride.

Abitbol V, Mary JY, Roux C, Soulé JC, Belaiche J, Dupas JL, Gendre JP, Lerebours E, Chaussade S; Groupe D'etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).

Aliment Pharmacol Ther. 2002 May;16(5):919-27.PMID: 11966500 [PubMed - indexed for MEDLINE]Related articlesFree article

Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.

Ringe JD, Faber H, Fahramand P, Schacht E.

J Rheumatol Suppl. 2005 Sep;76:33-40.PMID: 16142849 [PubMed - indexed for MEDLINE]Related articles

A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease.

Abitbol V, Briot K, Roux C, Roy C, Seksik P, Charachon A, Bouhnik Y, Coffin B, Allez M, Lamarque D, Chaussade S.

Clin Gastroenterol Hepatol. 2007 Oct;5(10):1184-9. Epub 2007 Aug 1.PMID: 17683996 [PubMed - indexed for MEDLINE]Related articles

Intravenous pamidronate in combination with calcium and vitamin D: highly effective in the treatment of low bone mineral density in inflammatory bowel disease.

Stokkers PC, Deley M, Van Der Spek M, Verberne HJ, Van Deventer SJ, Hommes DW.

Scand J Gastroenterol. 2006 Feb;41(2):200-4.PMID: 16484125 [PubMed - indexed for MEDLINE]Related articles

Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection.

Mondy K, Powderly WG, Claxton SA, Yarasheski KH, Royal M, Stoneman JS, Hoffmann ME, Tebas P.

J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):426-31.PMID: 15764959 [PubMed - indexed for MEDLINE]Related articles

Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis.

Ringe JD, Dorst A, Faber H, Schacht E, Rahlfs VW.

Rheumatol Int. 2004 Mar;24(2):63-70. Epub 2003 Sep 25.PMID: 14513268 [PubMed - indexed for MEDLINE]Related articles